Global Liver Transplantation Market, By Product Type (Organ Preservation Solutions, Immunosuppressive Drugs and Others), End User (Hospitals, Transplant Centres, Ambulatory Surgical Centres, and Others), Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment, Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil), Application (Replacement of Skin, Cornea, Bones, Heart Valves, Tendons, Nerves and Veins) – Industry Trends and Forecast to 2030.
Liver Transplantation Market Analysis and Size
Major factors driving the growth of this market are the rising prevalence of hepatitis A, B, and C rises. In India, life expectancy after a liver transplant is 86% after one year and 78% after three years. Furthermore, the procedure's long-term success rate is very high. After 15 to 20 years, you should have a 65 to 70% chance of survival. However, no surgical procedure is without risks. This complex procedure carries a 3–5% risk of death. Patients who receive a liver from a living donor have higher short-term survival rates than those who receive a liver from a deceased donor.
Data Bridge Market Research analyses that the liver transplantation market which was USD 1.5 billion in 2022, is expected to reach USD 2.52 billion by 2030, at a CAGR of 6.70% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Liver Transplantation Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Organ Preservation Solutions, Immunosuppressive Drugs and Others), End User (Hospitals, Transplant Centres, Ambulatory Surgical Centres, and Others), Treatment (Liver Transplantation Surgery, Post-Surgery Anti-Rejection Treatment, Cyclosporine, Tacrolimus, Sirolimus, Prednisone, Azathioprine, Mycophenolate Mofetil), Application (Replacement of Skin, Cornea, Bones, Heart Valves, Tendons, Nerves and Veins)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
AlloSource (U.S.), SJ Corporation Limited (U.S.), Dompé farmaceutici S.p.A. (Italy), Thompson Surgical (U.S.), Integra Life Sciences (U.S.), AbbVie Inc. (U.S.), North Chicago Illinois (U.S.), Arthrex Inc (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), Novartis AG (Germany), Stryker (U.S.), 21st Century Medicine (U.S.), BioLife Solutions (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Veloxis Pharmaceuticals Inc (U.S.), RedHill Biopharma Ltd. (Israel)
|
|
Market Opportunities
|
|
Market Definition
A liver transplant is a surgical procedure that replaces a patient's diseased liver with a healthy liver from another person. A whole liver or a liver segment may be replaced through liver transplantation. Transplantation is typically used to treat patients who have end-stage liver disease or acute liver failure. It is a tightly controlled procedure. As a result, it is only done at designated medical centres by highly trained physicians and support teams. Major life changes are required following surgery, because transplantation is a high-risk and resource-intensive procedure. Family members, parents, siblings, children, spouses, or volunteers who can donate their liver are the most preferred donors.
Liver Transplantation Market Dynamics
Drivers
- Rising prevalence of hepatitis
As the global prevalence of hepatitis A, B, and C rises, the liver transplantation market is growing. The most common cause of acute hepatitis was HAV (26.96%), followed by HEV (17.97%), HBV (16.10%), and HCV (11.98%). Co-infections with multiple viruses were found in 34 cases, with HAV-HEV co-infection being the most common. HEV was the leading cause of acute hepatic failure, followed by HAV and HEV co-infection. The advancement of treatment and increased adoption as the most effective method of managing end-stage liver disease is a major driving force in the liver transplantation market.
- Rise of passive lifestyles
The market will experience significant growth as a result of the rise of passive lifestyles such as poor eating habits, excessive drinking, and drug abuse which effects or damages the liver. These are the main factors driving the market's growth.
Furthermore, the growing geriatric population, as well as various causes of liver failure in the global population, have increased demand for liver transplants in various regions.
Opportunities
- Rising number of awareness programmes
An increase in the number of programmes aimed at raising awareness about early detection of liver cancer is expected to play a significant role in increasing demand for its diagnostic products. In 2018, the National Cancer Institute (NCI) funded a research programme at Michigan Medicine to improve liver cancer surveillance and facilitate early detection in the United States. Collaborations and partnerships to increase liver cancer screening undertaken by the National Cervical Cancer Coalition, WHO, the Centers for Disease Control and Prevention, the United States Preventive Services Task Force, and others are also among the major factors driving market growth during the forecast period.
Restraints/Challenges
- High cost of transplantation
The growth in the liver transplantation market may be hampered during the forecast period due to a lack of liver donors, an increase in hospitalization time and costs and increased waiting lists for liver transplants. As a result, liver transplantation market share will decline in the near future.
This liver transplantation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the liver transplantation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Liver Transplantation Market
The prevalence of lockdowns in various countries worldwide and the COVID-19 outbreak hampered the growth of the global liver transplantation market. Lockdowns increased the focus and reliance on COVID-19 infected patients, because of the disease's high fatality rate. The diagnostic treatments for liver disease have been delayed or cancelled, due to the rise in coronavirus cases. Aside from that, the COVID-19 pandemic increased public awareness of physical, mental, and emotional well-being. This has increased awareness about liver disease diagnosis and the frequency of regular check-ups using liver disease diagnostics. As a result, such progress is expected to stabilize and propel the market forward.
Recent Developments
- In 2022, XVIVO received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its Liver Assist device, which is intended to preserve donor livers before transplantation using oxygenated machine perfusion. Certain medical devices will be developed and reviewed more quickly and efficiently than previous therapies through the FDA's Breakthrough Device Program to treat or diagnose life-threatening or irreversible diseases.
- In 2022, The Transplant Authority of Tamil Nadu awarded Rela Hospital the award of appreciation for liver transplants in three categories. Mohamed Rela, the hospital's chairman, and his team received an appreciation award for performing the most paediatric liver transplants under the Chief Minister's Comprehensive Health Insurance Scheme (CMCHIS) and liver transplantation in 2010.
Global Liver Transplantation Market Scope
The liver transplantation market is segmented on the basis of product type, treatment, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Organ Preservation Solutions
- Immunosuppressive Drugs
- Others
End User
- Hospitals
- Transplant Centres
- Ambulatory Surgical Centres
- Others
Treatment
- Liver Transplantation Surgery
- Post-Surgery Anti-Rejection Treatment
- Cyclosporine
- Tacrolimus
- Sirolimus
- Prednisone
- Azathioprine
- Mycophenolate Mofetil
Application
- Replacement of Skin
- Cornea, Bones
- Heart Valves
- Tendons
- Nerves
- Veins
Liver Transplantation Market Regional Analysis/Insights
The liver transplantation market is analyzed and market size insights and trends are provided by country, product type, treatment, application and end users as referenced above.
The countries covered in the liver transplantation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the liver transplantation market because of the best infrastructure, advanced technology and awareness.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the rapid increase in the healthcare infrastructure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The liver transplantation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for liver transplantation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the liver transplantation market. The data is available for historic period 2011-2021.
Competitive Landscape and Liver Transplantation Market Share Analysis
The liver transplantation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to liver transplantation market.
Some of the major players operating in the liver transplantation market are:
- AlloSource (U.S.)
- SJ Corporation Limited (U.S.)
- Dompé farmaceutici S.p.A. (Italy)
- Thompson Surgical (U.S.)
- Integra Life Sciences (U.S.)
- AbbVie Inc. (U.S.)
- North Chicago Illinois (U.S.)
- Arthrex Inc (U.S.)
- Zimmer Biomet (U.S.)
- Medtronic (Ireland)
- Novartis AG (Germany)
- Stryker (U.S.)
- 21st Century Medicine (U.S.)
- BioLife Solutions (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel )
- Veloxis Pharmaceuticals Inc (U.S.)
- RedHill Biopharma Ltd. (Israel)
SKU-